SUBSTIPHARM
Jean-Jacques Cavelier is currently the Directeur des Opérations Industrielles at SUBSTIPHARM, overseeing the industrialization of new products and managing a portfolio of B2B and B2C products. Previously, Jean-Jacques worked as a Responsable industriel at Delpharm and as a Directeur CMC at PlastoPharma. Jean-Jacques has a strong background in development and management of pharmaceutical products, with experience in areas such as validation, analytical methods, and regulatory affairs. Jean-Jacques holds a degree in Ingénieur Développement produit, Biochimie from École de Biologie Industrielle.
SUBSTIPHARM
Substipharm is a privately held pharmaceutical Group. We develop, supply and commercialize pharmaceuticals in more than 60 countries worldwide. Our portfolio of products that we currently license out or distribute directly or through partners comprises more than 60 different molecules. Our development pipeline includes as well more than 40 ongoing projects. We have a successful portfolio of pharmaceutical products and vaccines including: Mature brands Generics Over the counter (OTC) pharmaceuticals Difficult to develop medicines Value added presentations Biological products including vaccines: